𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Variation of benzbromarone elimination in man — a population study

✍ Scribed by I. Walter-Sack; U. Gresser; M. Adjan; I. Kamilli; A. Ittensohn; J. X. Vries; E. Weber; N. Zöllner

Publisher
Springer
Year
1990
Tongue
English
Weight
465 KB
Volume
39
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis

The plasma benzbromarone concentration-time profile in a healthy subject who retained the compound much longer than other individuals is described. The data suggested that determination of the 24 h plasma concentration of the parent drug after a single oral dose of 100 mg benzbromarone would be an appropriate procedure to determine the elimination phenotype. Based on this procedure, 148 of 153 healthy individuals (97%) in a population study were found to eliminate benzbromarone rapidly. In one subject the 24 h benzbromarone plasma concentration was very similar to that observed in the individual who had been more fully characterized. Four participants gave intermediate results. The data are compatible with a bimodal or trimodal distribution of different benzbromarone elimination phenotypes.

📜 SIMILAR VOLUMES

Rapid and slow benzbromarone elimination
Rapid and slow benzbromarone elimination phenotypes in man: benzbromarone and metabolite profiles
✍ I. Walter-Sack; J. X. Vries; A. Ittensohn; E. Weber 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 473 KB

Following oral administration of the uricosuric drug benzbromarone two major metabolites appear in the circulation. 1'-hydroxy-benzbromarone (M1), and a second product (M2) of unknown structure. The plasma concentrations of the parent drug and of M1 and M2 have now been compared in two different eli

Benzbromarone hydroxylation in man: defe
Benzbromarone hydroxylation in man: defective formation of the 6-hydroxybenzbromarone metabolite
✍ Vries, J.X. ;Walter-Sack, I. ;Ittensohn, A. ;Weber, E. ;Empl, H. ;Gresser, U. ;Z 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 492 KB

To determine the elimination phenotype of the uricosuric agent benzbromarone 100 mg of the drug was administered as a single oral dose to 11 volunteers on a formula diet; plasma concentration-time profiles of the parent drug and the main metabolites M 1 (l'-hydroxybenzbromarone) and M 2 (6-hydroxy-b